OSRH Stock Analysis: Buy, Sell, or Hold?
OSRH - OSR Holdings, Inc. Common Stock
$0.56
-0.02 (-4.26%)
▼
5d:
-22.35%
30d:
-0.89%
90d:
-14.6%
WAIT
LOW Confidence
Last Updated: February 2, 2026
Get Alerted When OSRH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called OSRH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: OSRH is down 22.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: OSRH is down 22.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: OSRH is currently trading at $0.56, which is considered oversold relative to its 30-day fair value range of $0.59 to $0.74.
Technical Outlook: Technically, OSRH is in a strong downtrend. The price is currently testing key support at $0.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+1688.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSRH is in a strong downtrend. The price is currently testing key support at $0.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+1688.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.59 -
$0.74
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 1688.6% below Wall St target ($10.00)
- WARNING: Recommendation downgraded due to -22.3% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.59 -
$0.74
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.58
Resistance Level
$0.84
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.51
Wall Street Target
$10.00
(+1688.6%)
Revenue Growth (YoY)
-23.7%
Last updated: February 03, 2026 5:51 AM ET
Data refreshes hourly during market hours. Next update: 6:51 AM
Data refreshes hourly during market hours. Next update: 6:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSRH showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
